These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 20050968)

  • 1. Increased Dickkopf-1 expression in transgenic mouse models of neurodegenerative disease.
    Rosi MC; Luccarini I; Grossi C; Fiorentini A; Spillantini MG; Prisco A; Scali C; Gianfriddo M; Caricasole A; Terstappen GC; Casamenti F
    J Neurochem; 2010 Mar; 112(6):1539-51. PubMed ID: 20050968
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Truncated tau at D421 is associated with neurodegeneration and tangle formation in the brain of Alzheimer transgenic models.
    Zhang Q; Zhang X; Sun A
    Acta Neuropathol; 2009 Jun; 117(6):687-97. PubMed ID: 19190923
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Alpha1-antichymotrypsin, an inflammatory protein overexpressed in Alzheimer's disease brain, induces tau phosphorylation in neurons.
    Padmanabhan J; Levy M; Dickson DW; Potter H
    Brain; 2006 Nov; 129(Pt 11):3020-34. PubMed ID: 16987932
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Decreased nuclear beta-catenin, tau hyperphosphorylation and neurodegeneration in GSK-3beta conditional transgenic mice.
    Lucas JJ; Hernández F; Gómez-Ramos P; Morán MA; Hen R; Avila J
    EMBO J; 2001 Jan; 20(1-2):27-39. PubMed ID: 11226152
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tau transgenic mice as models for cerebrospinal fluid tau biomarkers.
    Barten DM; Cadelina GW; Hoque N; DeCarr LB; Guss VL; Yang L; Sankaranarayanan S; Wes PD; Flynn ME; Meredith JE; Ahlijanian MK; Albright CF
    J Alzheimers Dis; 2011; 24 Suppl 2():127-41. PubMed ID: 21422517
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Calretinin interneurons are early targets of extracellular amyloid-beta pathology in PS1/AbetaPP Alzheimer mice hippocampus.
    Baglietto-Vargas D; Moreno-Gonzalez I; Sanchez-Varo R; Jimenez S; Trujillo-Estrada L; Sanchez-Mejias E; Torres M; Romero-Acebal M; Ruano D; Vizuete M; Vitorica J; Gutierrez A
    J Alzheimers Dis; 2010; 21(1):119-32. PubMed ID: 20413859
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Activation of Wnt signaling by lithium and rosiglitazone reduced spatial memory impairment and neurodegeneration in brains of an APPswe/PSEN1DeltaE9 mouse model of Alzheimer's disease.
    Toledo EM; Inestrosa NC
    Mol Psychiatry; 2010 Mar; 15(3):272-85, 228. PubMed ID: 19621015
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mutations in amyloid precursor protein and presenilin-1 genes increase the basal oxidative stress in murine neuronal cells and lead to increased sensitivity to oxidative stress mediated by amyloid beta-peptide (1-42), HO and kainic acid: implications for Alzheimer's disease.
    Mohmmad Abdul H; Sultana R; Keller JN; St Clair DK; Markesbery WR; Butterfield DA
    J Neurochem; 2006 Mar; 96(5):1322-35. PubMed ID: 16478525
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neurodegenerative changes associated with beta-amyloid deposition in the brains of mice carrying mutant amyloid precursor protein and mutant presenilin-1 transgenes.
    Kurt MA; Davies DC; Kidd M; Duff K; Rolph SC; Jennings KH; Howlett DR
    Exp Neurol; 2001 Sep; 171(1):59-71. PubMed ID: 11520121
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hippocampal neuronal subpopulations are differentially affected in double transgenic mice overexpressing frontotemporal dementia and parkinsonism linked to chromosome 17 tau and glycogen synthase kinase-3beta.
    Engel T; Goñi-Oliver P; Gomez-Ramos P; Morán MA; Lucas JJ; Avila J; Hernández F
    Neuroscience; 2008 Dec; 157(4):772-80. PubMed ID: 18951953
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Formation of filamentous tau aggregations in transgenic mice expressing V337M human tau.
    Tanemura K; Akagi T; Murayama M; Kikuchi N; Murayama O; Hashikawa T; Yoshiike Y; Park JM; Matsuda K; Nakao S; Sun X; Sato S; Yamaguchi H; Takashima A
    Neurobiol Dis; 2001 Dec; 8(6):1036-45. PubMed ID: 11741399
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Phosphorylation of Tau at S422 is enhanced by Abeta in TauPS2APP triple transgenic mice.
    Grueninger F; Bohrmann B; Czech C; Ballard TM; Frey JR; Weidensteiner C; von Kienlin M; Ozmen L
    Neurobiol Dis; 2010 Feb; 37(2):294-306. PubMed ID: 19781645
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nitric oxide synthase 3-mediated neurodegeneration after intracerebral gene delivery.
    de la Monte SM; Jhaveri A; Maron BA; Wands JR
    J Neuropathol Exp Neurol; 2007 Apr; 66(4):272-83. PubMed ID: 17413318
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Aberrant expressions of pathogenic phenotype in Alzheimer's diseased transgenic mice carrying NSE-controlled APPsw.
    Hwang DY; Cho JS; Lee SH; Chae KR; Lim HJ; Min SH; Seo SJ; Song YS; Song CW; Paik SG; Sheen YY; Kim YK
    Exp Neurol; 2004 Mar; 186(1):20-32. PubMed ID: 14980807
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tau kinase I overexpression induces dentate gyrus degeneration.
    Avila J; Gómez de Barreda E; Engel T; Pérez M; Martín-Maestro P; Fuster-Matanzo A; Goñi-Oliver P; Lucas JJ; Hernández F
    Neurodegener Dis; 2010; 7(1-3):13-5. PubMed ID: 20160451
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Wnt signaling in Alzheimer's disease: up or down, that is the question.
    Boonen RA; van Tijn P; Zivkovic D
    Ageing Res Rev; 2009 Apr; 8(2):71-82. PubMed ID: 19101658
    [TBL] [Abstract][Full Text] [Related]  

  • 17. SUMO-1 immunoreactivity co-localizes with phospho-Tau in APP transgenic mice but not in mutant Tau transgenic mice.
    Takahashi K; Ishida M; Komano H; Takahashi H
    Neurosci Lett; 2008 Aug; 441(1):90-3. PubMed ID: 18586401
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Analysis of the cholinergic pathology in the P301L tau transgenic pR5 model of tauopathy.
    Köhler C; Bista P; Götz J; Schröder H
    Brain Res; 2010 Aug; 1347():111-24. PubMed ID: 20513372
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tau overexpression in transgenic mice induces glycogen synthase kinase 3beta and beta-catenin phosphorylation.
    Shim SB; Lim HJ; Chae KR; Kim CK; Hwang DY; Jee SW; Lee SH; Sin JS; Leem YH; Lee SH; Cho JS; Lee HH; Choi SY; Kim YK
    Neuroscience; 2007 May; 146(2):730-40. PubMed ID: 17337327
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Signal transduction during amyloid-beta-peptide neurotoxicity: role in Alzheimer disease.
    Fuentealba RA; Farias G; Scheu J; Bronfman M; Marzolo MP; Inestrosa NC
    Brain Res Brain Res Rev; 2004 Dec; 47(1-3):275-89. PubMed ID: 15572177
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.